{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:14:24Z","timestamp":1792462464312,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060152"],"award-info":[{"award-number":["No. 82060152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-024-01819-7","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T04:37:07Z","timestamp":1736829427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of levothyroxine therapy on bone and mineral metabolism in hypothyroidism: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaotao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"issue":"2","key":"1819_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.2019.9052","volume":"322","author":"B Biondi","year":"2019","unstructured":"Biondi B, Cappola AR, Subclinical Hypothyroidism. Rev Jama. 2019;322(2):153\u201360. https:\/\/doi.org\/10.1001\/jama.2019.9052.","journal-title":"Rev Jama"},{"issue":"1","key":"1819_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-022-00357-7","volume":"8","author":"L Chaker","year":"2022","unstructured":"Chaker L, Razvi S, Bensenor IM, et al. Hypothyroidism Nat Rev Dis Primers. 2022;8(1):30. https:\/\/doi.org\/10.1038\/s41572-022-00357-7.","journal-title":"Hypothyroidism Nat Rev Dis Primers"},{"issue":"2","key":"1819_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1210\/er.2015-1106","volume":"37","author":"JH Bassett","year":"2016","unstructured":"Bassett JH. Role of thyroid hormones in skeletal development and bone maintenance. Endocr Rev. 2016;37(2):135\u201387. https:\/\/doi.org\/10.1210\/er.2015-1106.","journal-title":"Endocr Rev"},{"issue":"1","key":"1819_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40618-017-0753-4","volume":"41","author":"GR Williams","year":"2018","unstructured":"Williams GR. Thyroid diseases and bone health. J Endocrinol Invest. 2018;41(1):99\u2013109. https:\/\/doi.org\/10.1007\/s40618-017-0753-4.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1819_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4248\/br201302004","volume":"1","author":"HY Kim","year":"2013","unstructured":"Kim HY. Role and mechanisms of actions of thyroid hormone on the skeletal development. Bone Res. 2013;1(2):146\u201361. https:\/\/doi.org\/10.4248\/br201302004.","journal-title":"Bone Res"},{"issue":"1","key":"1819_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12902-021-00715-8","volume":"21","author":"T Deng","year":"2021","unstructured":"Deng T, Zhang W, Zhang Y, et al. Thyroid-stimulating hormone decreases the risk of osteoporosis by regulating osteoblast proliferation and differentiation. BMC Endocr Disord. 2021;21(1):49. https:\/\/doi.org\/10.1186\/s12902-021-00715-8.","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"1819_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/105072502760043503","volume":"12","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P. Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid. 2002;12(5):411\u20139. https:\/\/doi.org\/10.1089\/105072502760043503.","journal-title":"Thyroid"},{"issue":"11","key":"1819_CR8","doi-asserted-by":"publisher","first-page":"e2240823","DOI":"10.1001\/jamanetworkopen.2022.40823","volume":"5","author":"NR Daya","year":"2022","unstructured":"Daya NR, Fretz A, Martin SS, et al. Association between subclinical thyroid dysfunction and fracture risk. JAMA Netw Open. 2022;5(11):e2240823. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.40823.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1819_CR9","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/jbmr.2416","volume":"30","author":"B Abrahamsen","year":"2015","unstructured":"Abrahamsen B, J\u00f8rgensen HL, Laulund AS, et al. The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register-based time-resolved cohort analysis. J Bone Min Res. 2015;30(5):898\u2013905. https:\/\/doi.org\/10.1002\/jbmr.2416.","journal-title":"J Bone Min Res"},{"issue":"10101","key":"1819_CR10","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/s0140-6736(17)30703-1","volume":"390","author":"L Chaker","year":"2017","unstructured":"Chaker L, Bianco AC, Jonklaas J, et al. Hypothyroidism Lancet. 2017;390(10101):1550\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(17)30703-1.","journal-title":"Hypothyroidism Lancet"},{"issue":"10460","key":"1819_CR11","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/s0140-6736(24)01614-3","volume":"404","author":"PN Taylor","year":"2024","unstructured":"Taylor PN, Medici MM, Hubalewska-Dydejczyk A, et al. Hypothyroidism Lancet. 2024;404(10460):1347\u201364. https:\/\/doi.org\/10.1016\/s0140-6736(24)01614-3.","journal-title":"Hypothyroidism Lancet"},{"issue":"2","key":"1819_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11914-009-0009-0","volume":"7","author":"M Zaidi","year":"2009","unstructured":"Zaidi M, Davies TF, Zallone A, et al. Thyroid-stimulating hormone, thyroid hormones, and bone loss. Curr Osteoporos Rep. 2009;7(2):47\u201352. https:\/\/doi.org\/10.1007\/s11914-009-0009-0.","journal-title":"Curr Osteoporos Rep"},{"key":"1819_CR13","doi-asserted-by":"publisher","first-page":"103503","DOI":"10.1016\/j.amsu.2022.103503","volume":"76","author":"S Ochani","year":"2022","unstructured":"Ochani S, Siddiqui A. Adverse effects of long-term levothyroxine therapy in subclinical hypothyroidism. Ann Med Surg (Lond). 2022;76:103503. https:\/\/doi.org\/10.1016\/j.amsu.2022.103503.","journal-title":"Ann Med Surg (Lond)"},{"issue":"3","key":"1819_CR14","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1210\/jc.2017-01986","volume":"103","author":"G Mazziotti","year":"2018","unstructured":"Mazziotti G, Formenti AM, Frara S, et al. High prevalence of Radiological Vertebral fractures in women on thyroid-stimulating hormone-suppressive therapy for thyroid carcinoma. J Clin Endocrinol Metab. 2018;103(3):956\u201364. https:\/\/doi.org\/10.1210\/jc.2017-01986.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1819_CR15","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1210\/clinem\/dgab539","volume":"106","author":"EJ Ku","year":"2021","unstructured":"Ku EJ, Yoo WS, Lee EK, et al. Effect of TSH suppression therapy on bone Mineral density in differentiated thyroid Cancer: a systematic review and Meta-analysis. J Clin Endocrinol Metab. 2021;106(12):3655\u201367. https:\/\/doi.org\/10.1210\/clinem\/dgab539.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1819_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1691\/ph.2022.2436","volume":"77","author":"HF Alotaibe","year":"2022","unstructured":"Alotaibe HF, Alolaiwi LA, Almutairi A, et al. Association between levothyroxine replacement therapy and osteoporosis in Riyadh, Saudi Arabia: a matched case-control study. Pharmazie. 2022;77(10):295\u20138. https:\/\/doi.org\/10.1691\/ph.2022.2436.","journal-title":"Pharmazie"},{"issue":"3","key":"1819_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00198-003-1527-8","volume":"15","author":"C Meier","year":"2004","unstructured":"Meier C, Beat M, Guglielmetti M, et al. Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial. Osteoporos Int. 2004;15(3):209\u201316. https:\/\/doi.org\/10.1007\/s00198-003-1527-8.","journal-title":"Osteoporos Int"},{"key":"1819_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/cmwh.S22114","volume":"8","author":"RP Babu","year":"2015","unstructured":"Babu RP, Christy A, Hegde A, et al. Do premenopausal hypothyroid women on levothyroxine therapy need bone status monitoring? Clin Med Insights Womens Health. 2015;8:1\u20136. https:\/\/doi.org\/10.4137\/cmwh.S22114.","journal-title":"Clin Med Insights Womens Health"},{"issue":"1","key":"1819_CR19","first-page":"18","volume":"38","author":"R Chai","year":"1999","unstructured":"Chai R, Ye Z, Zhan Z, et al. The effects of levothyroxine replacement therapy on bone and mineral metabolism in patients with hypothyroidism. Zhonghua Nei Ke Za Zhi. 1999;38(1):18\u201321.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"5","key":"1819_CR20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.5114\/aoms.2015.54855","volume":"11","author":"JD Pedrera-Zamorano","year":"2015","unstructured":"Pedrera-Zamorano JD, Roncero-Martin R, Calderon-Garcia JF, et al. Treatment of subclinical hypothyroidism does not affect bone mass as determined by dual-energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative bone ultrasound in Spanish women. Arch Med Sci. 2015;11(5):1008\u201314. https:\/\/doi.org\/10.5114\/aoms.2015.54855.","journal-title":"Arch Med Sci"},{"key":"1819_CR21","doi-asserted-by":"publisher","unstructured":"Gonzalez Rodriguez E, Stuber M, Del Giovane C, et al. Skeletal effects of Levothyroxine for subclinical hypothyroidism in older adults: a TRUST Randomized Trial Nested Study. J Clin Endocrinol Metab. 2020;105(1). https:\/\/doi.org\/10.1210\/clinem\/dgz058.","DOI":"10.1210\/clinem\/dgz058"},{"issue":"4","key":"1819_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1365-2265.1994.tb02572.x","volume":"41","author":"J Franklyn","year":"1994","unstructured":"Franklyn J, Betteridge J, Holder R, et al. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis. Clin Endocrinol (Oxf). 1994;41(4):425\u201332. https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02572.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1819_CR23","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"4","key":"1819_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1365-2265.1994.tb02572.x","volume":"41","author":"J Franklyn","year":"1994","unstructured":"Franklyn J, Betteridge J, Holder R, et al. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis. Clin Endocrinol. 1994;41(4):425\u201332. https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02572.x.","journal-title":"Clin Endocrinol"},{"key":"1819_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/BMI.S13965","volume":"9","author":"AL Christy","year":"2014","unstructured":"Christy AL, D\u2019Souza V, Babu RP, et al. Utility of C-terminal telopeptide in evaluating levothyroxine replacement therapy-induced bone loss. Biomark Insights. 2014;9:1\u20136. https:\/\/doi.org\/10.4137\/BMI.S13965.","journal-title":"Biomark Insights"},{"issue":"2","key":"1819_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12020-020-02398-y","volume":"71","author":"ML Obling","year":"2021","unstructured":"Obling ML, Nicolaisen P, Brix TH, et al. Restoration of euthyroidism in women with Hashimoto\u2019s thyroiditis changes bone microarchitecture but not estimated bone strength. Endocrine. 2021;71(2):397\u2013406. https:\/\/doi.org\/10.1007\/s12020-020-02398-y.","journal-title":"Endocrine"},{"issue":"20","key":"1819_CR27","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1001\/jama.265.20.2688","volume":"265","author":"AW Kung","year":"1991","unstructured":"Kung AW. Bone mineral density in premenopausal women receiving long-term physiological doses of levothyroxine. Jama-Journal Am Med Association. 1991;265(20):2688\u201391. https:\/\/doi.org\/10.1001\/jama.265.20.2688.","journal-title":"Jama-Journal Am Med Association"},{"issue":"6","key":"1819_CR28","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1530\/eje.0.1340702","volume":"134","author":"BL Langdahl","year":"1996","unstructured":"Langdahl BL, Loft AGR, Eriksen EF, et al. Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy. Eur J Endocrinol. 1996;134(6):702\u20139. https:\/\/doi.org\/10.1530\/eje.0.1340702.","journal-title":"Eur J Endocrinol"},{"key":"1819_CR29","unstructured":"Liu J. Changes of partial bone metabolic indexes before and after treatment for patients with hypothyroidism. Chin J Osteoporos, 2011;17(12)."},{"issue":"4","key":"1819_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0002-9343(93)90307-B","volume":"95","author":"DS Ross","year":"1993","unstructured":"Ross DS. Bone density is not reduced during the short-term administration of levothyroxine to postmenopausal women with subclinical hypothyroidism: a randomized, prospective study. Am J Med. 1993;95(4):385\u20138. https:\/\/doi.org\/10.1016\/0002-9343(93)90307-B.","journal-title":"Am J Med"},{"key":"1819_CR31","unstructured":"Chen F. Effects of thyroxine on serum lipid and bone metabolism in elderly patients with subclinical hypothyroidism. Chin J Geriatr, 2003;22(7)."},{"key":"1819_CR32","unstructured":"Nie Y. Effects of levothyroxine on serum lipid and bone metabolism in elderly patients with subclinical hypothyroidism. Chin Foreign Med Res, 2016;14(9)."},{"key":"1819_CR33","doi-asserted-by":"publisher","first-page":"913749","DOI":"10.3389\/fendo.2022.913749","volume":"13","author":"C Zhao","year":"2022","unstructured":"Zhao C, Wang Y, Xiao L, et al. Effect of levothyroxine on older patients with subclinical hypothyroidism: a systematic review and Meta-analysis. Front Endocrinol (Lausanne). 2022;13:913749. https:\/\/doi.org\/10.3389\/fendo.2022.913749.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1819_CR34","doi-asserted-by":"publisher","unstructured":"B\u00fcchi AE, Feller M, Netzer S, et al. Bone geometry in older adults with subclinical hypothyroidism upon levothyroxine therapy: a nested study within a randomized placebo controlled trial. Bone. 2022;161. https:\/\/doi.org\/10.1016\/j.bone.2022.116404.","DOI":"10.1016\/j.bone.2022.116404"},{"issue":"2","key":"1819_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0092-8674(03)00771-2","volume":"115","author":"E Abe","year":"2003","unstructured":"Abe E, Marians RC, Yu W, et al. TSH is a negative regulator of skeletal remodeling. Cell. 2003;115(2):151\u201362. https:\/\/doi.org\/10.1016\/s0092-8674(03)00771-2.","journal-title":"Cell"},{"issue":"1","key":"1819_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jcp.20041","volume":"201","author":"M Kanatani","year":"2004","unstructured":"Kanatani M, Sugimoto T, Sowa H, et al. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction. J Cell Physiol. 2004;201(1):17\u201325. https:\/\/doi.org\/10.1002\/jcp.20041.","journal-title":"J Cell Physiol"},{"issue":"4","key":"1819_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1006\/bbrc.2002.6561","volume":"291","author":"M Miura","year":"2002","unstructured":"Miura M, Tanaka K, Komatsu Y, et al. A novel interaction between thyroid hormones and 1,25(OH)(2)D(3) in osteoclast formation. Biochem Biophys Res Commun. 2002;291(4):987\u201394. https:\/\/doi.org\/10.1006\/bbrc.2002.6561.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1819_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/2279-042x.141099","volume":"3","author":"M Karimifar","year":"2014","unstructured":"Karimifar M, Esmaili F, Salari A, et al. Effects of Levothyroxine and thyroid stimulating hormone on bone loss in patients with primary hypothyroidism. J Res Pharm Pract. 2014;3(3):83\u20137. https:\/\/doi.org\/10.4103\/2279-042x.141099.","journal-title":"J Res Pharm Pract"},{"issue":"5","key":"1819_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1530\/eje.0.1420445","volume":"142","author":"P Hadji","year":"2000","unstructured":"Hadji P, Hars O, Sturm G, et al. The effect of long-term, non-suppressive levothyroxine treatment on quantitative ultrasonometry of bone in women. Eur J Endocrinol. 2000;142(5):445\u201350. https:\/\/doi.org\/10.1530\/eje.0.1420445.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1819_CR40","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00198-014-2906-z","volume":"26","author":"HM Noh","year":"2015","unstructured":"Noh HM, Park YS, Lee J, et al. A cross-sectional study to examine the correlation between serum TSH levels and the osteoporosis of the lumbar spine in healthy women with normal thyroid function. Osteoporos Int. 2015;26(3):997\u20131003. https:\/\/doi.org\/10.1007\/s00198-014-2906-z.","journal-title":"Osteoporos Int"},{"key":"1819_CR41","doi-asserted-by":"publisher","first-page":"1039079","DOI":"10.3389\/fendo.2022.1039079","volume":"13","author":"N Sheng","year":"2022","unstructured":"Sheng N, Xing F, Wang J, et al. T4 rather than TSH correlates with BMD among euthyroid adults. Front Endocrinol (Lausanne). 2022;13:1039079. https:\/\/doi.org\/10.3389\/fendo.2022.1039079.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1819_CR42","doi-asserted-by":"publisher","first-page":"e043007","DOI":"10.1136\/bmjopen-2020-043007","volume":"11","author":"D Kwak","year":"2021","unstructured":"Kwak D, Ha J, Won Y, et al. Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis. BMJ Open. 2021;11(5):e043007. https:\/\/doi.org\/10.1136\/bmjopen-2020-043007.","journal-title":"BMJ Open"},{"issue":"5","key":"1819_CR43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2265.1997.3221125.x","volume":"47","author":"G De Rosa","year":"1997","unstructured":"De Rosa G, Testa A, Giacomini D, et al. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre. Clin Endocrinol (Oxf). 1997;47(5):529\u201335. https:\/\/doi.org\/10.1046\/j.1365-2265.1997.3221125.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"1819_CR44","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1210\/jc.2012-2570","volume":"97","author":"R Schneider","year":"2012","unstructured":"Schneider R, Schneider M, Reiners C, et al. Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study. J Clin Endocrinol Metab. 2012;97(11):3926\u201334. https:\/\/doi.org\/10.1210\/jc.2012-2570.","journal-title":"J Clin Endocrinol Metab"},{"key":"1819_CR45","doi-asserted-by":"publisher","unstructured":"Delitala AP, Scuteri A. Thyroid hormone diseases and osteoporosis. J Clin Med. 2020;9(4). https:\/\/doi.org\/10.3390\/jcm9041034.","DOI":"10.3390\/jcm9041034"},{"issue":"5","key":"1819_CR46","first-page":"103","volume":"120","author":"M Korsic","year":"1998","unstructured":"Korsic M, Cvijetic S, Dekanic-Ozegovic D, et al. Bone mineral density in patients on long-term levothyroxine therapy. Lijec Vjesn. 1998;120(5):103\u20135.","journal-title":"Lijec Vjesn"},{"key":"1819_CR47","doi-asserted-by":"publisher","unstructured":"Krytskyy TI. State of bone mineral density in men with primary hypothyroidism. Osteoporos Int. 2020;31(SUPPL 1). https:\/\/doi.org\/10.1007\/s00198-020-05696-3. S517-S518.","DOI":"10.1007\/s00198-020-05696-3"},{"issue":"1","key":"1819_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.11005\/jbm.2019.26.1.31","volume":"26","author":"EH Kim","year":"2019","unstructured":"Kim EH, Jeon YK, Pak K, et al. Effects of Thyrotropin Suppression on Bone Health in Menopausal women with total thyroidectomy. J Bone Metab. 2019;26(1):31\u20138. https:\/\/doi.org\/10.11005\/jbm.2019.26.1.31.","journal-title":"J Bone Metab"},{"issue":"4","key":"1819_CR49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s001980050069","volume":"8","author":"E J\u00f3dar","year":"1998","unstructured":"J\u00f3dar E, Bego\u00f1a L\u00f3pez M, Garc\u00eda L, et al. Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass. Osteoporos Int. 1998;8(4):311\u20136. https:\/\/doi.org\/10.1007\/s001980050069.","journal-title":"Osteoporos Int"},{"issue":"10","key":"1819_CR50","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s40618-021-01537-0","volume":"44","author":"B\u00c9 Sousa","year":"2021","unstructured":"Sousa B\u00c9, Silva CA, de Oliveira Guidotti BC. Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy. J Endocrinol Invest. 2021;44(10):2295\u2013305. https:\/\/doi.org\/10.1007\/s40618-021-01537-0.","journal-title":"J Endocrinol Invest"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01819-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01819-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01819-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T16:32:42Z","timestamp":1736872362000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01819-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01819-7","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"15 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"11"}}